EUVIMEDEUVIMED entdecken
Multizentrische Studie

Evidence of Persistent Mild Hypercortisolism in Patients Medically Treated for Cushing Disease: the Haircush Study

Kamel Mohammedi, Jerome Bertherat, Gerald Raverot iD, Delphine Drui, Yves Reznik, Frederic Castinetti iD, Philippe Chanson iD, Manon Fafin, Julie Brossaud, Antoine Tabarin iD

The Journal of Clinical Endocrinology & Metabolism · 2023

DOI: 10.1210/clinem/dgad251 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Kamel Mohammedi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, French Reference Center for Adrenal Cancer, EURACAN European Expert Center on Rare Neuroendocrine Tumors, Hôpital Haut-L…. Hauptthemen laut MEDLINE: Pituitary ACTH Hypersecretion, Cortisone, Cushing Syndrome. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Novartis and HRA Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Cortisol-lowering drugs may not restore a normal cortisol secretion in Cushing disease (CD).

Objective

This work aimed to assess the long-term cortisol exposure in medically treated CD patients using hair-cortisol (HF) and hair-cortisone (HE) measurement.

Methods

This multicenter prospective study included 3 groups of female patients: CushMed = 16 treated with a stable cortisol-lowering drug dosage and normal urinary free cortisol (UFC); CushSurg = 13 cured by pituitary surgery; CushBla = 15 receiving stable recommended doses of hydrocortisone following bilateral adrenalectomy. Patients were evaluated for 3 months with their usual treatments. Two late-night saliva and 24-hour urine samples were collected monthly in CushMed, and at study end in CushSurg and CushBla patients. A 3-cm hair sample was collected at study end from all patients. Main outcome measures included clinical score and centralized measurement of UFC, late-night salivary cortisol (LNSF), late-night salivary cortisone (LNSE), HE, HF.

Results

Despite having almost all UFCs normalized, CushMed patients exhibited increased HE as compared to CushSurg controls (P = .003). CushMed patients also had increased clinical score (P = .001), UFC (P = .03), LNSF, LNSE (P = .0001), and variability in the latter parameters (P = .004). CushBla patients had increased HF and HE, contrasting with LNSEs similar to CushSurg patients. Six of 15 CushMed patients exhibited increased HE concentrations and had increased antihypertensive drug dosage compared to CushMed patients with normal HE (P = .05).

Conclusion

Despite normalized UFCs, a subset of medically treated CD patients displays an altered circadian rhythm of serum cortisol. A single HE measurement identifies chronic mild persistent hypercortisolism and could replace multiple saliva analyzes to monitor medical treatments in CD patients once UFC is normalized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary ACTH HypersecretionCortisoneCushing SyndromeHumansFemaleHydrocortisoneProspective StudiesSalivaCircadian Rhythm

Stichwörter der Autor:innen

Cushing diseasebilateral adrenalectomyhair cortisolhair cortisonelate-night salivary cortisonepharmacological treatment

Substanzen

HydrocortisoneCortisone

Autor:innen und Institutionen

  • Department of Endocrinology, French Reference Center for Adrenal Cancer, EURACAN European Expert Center on Rare Neuroendocrine Tumors, Hôpital Haut-Lévèque, CHU and University of Bordeaux, F-33604 Pessac, France.
  • Department of Endocrinology, French Reference Center for Rare Adrenal Disorders, Hôpital Cochin, Université Paris Cité, Institut Cochin, Inserm U1016, CNRS UMR8104, F-75014, Paris, France.
  • Department of Endocrinology, French Reference Center for Rare Pituitary Diseases HYPO, Hospices Civils de Lyon and Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, F-69001, L…
  • Department of Endocrinology and Institut du thorax, CHU de Nantes, F-44000 Nantes, France.
  • Department of Endocrinology and Diabetology, CHU Côte de Nacre, F-14033 Caen, France.
  • Department of Endocrinology, Assistance Publique-Hopitaux de Marseille, French Reference Center for Rare Pituitary Diseases, EURACAN European Expert Center on Rare Pituitary Tumors, La Conception Hospital, Aix Marseille…

ORCID-Profile: Gerald Raverot, Frederic Castinetti, Philippe Chanson, Antoine Tabarin

Förderung

  • Novartis and HRA Pharma

Zitieren

APA

Mohammedi, K., Bertherat, J., Raverot, G., Drui, D., Reznik, Y., Castinetti, F., Chanson, P., Fafin, M., Brossaud, J., & Tabarin, A. (2023). Evidence of Persistent Mild Hypercortisolism in Patients Medically Treated for Cushing Disease: the Haircush Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad251

Vancouver

Mohammedi K, Bertherat J, Raverot G, Drui D, Reznik Y, Castinetti F, et al. Evidence of Persistent Mild Hypercortisolism in Patients Medically Treated for Cushing Disease: the Haircush Study. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad251

BibTeX
@article{Mohammedi2023,
  author = {Mohammedi, Kamel and Bertherat, Jerome and Raverot, Gerald and Drui, Delphine and Reznik, Yves and Castinetti, Frederic and Chanson, Philippe and Fafin, Manon and Brossaud, Julie and Tabarin, Antoine},
  title = {Evidence of Persistent Mild Hypercortisolism in Patients Medically Treated for Cushing Disease: the Haircush Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  doi = {10.1210/clinem/dgad251}
}
Kostenlos starten →